CHEMOTHERAPY AND G-CSF PRIMED PERIPHERAL-BLOOD CD34 POSITIVE STEM-CELLS WHICH PROVIDE HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY CONTAIN A SUBSET OF HLA-DR NEGATIVE, CD38 NEGATIVE CELLS

被引：0

作者：

MAHARAJ, D ^{[1
]}

RILEY, R ^{[1
]}

ONEILL, GJ ^{[1
]}

PHILLIPS, J ^{[1
]}

ELIA, J ^{[1
]}

机构：

[1] UNIV MIAMI,SCH MED,DEPT MICROBIOL IMMUNOL,DIV HEMATOL ONCOL,BONE MARROW TRANSPLANT PROGRAM,MIAMI,FL 33152

来源：

BLOOD | 1993年 / 82卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A13 / A13

页数：1

共 50 条

[41] NUMBERS OF HUMAN CD34(+) HEMATOPOIETIC PROGENITOR CELLS MOBILIZED INTO PERIPHERAL-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES INCREASE IN-VITRO FOLLOWING A SHORT EXPOSURE TO STEM-CELL FACTOR [J].

SROUR, EF ;

TONG, J ;

EDER, P ;

BREGNI, M ;

SIENA, S ;

GIANNI, AM ;

HOFFMAN, R .

EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) :1184-1184

[42] CIRCULATION OF CD34+ HEMATOPOIETIC STEM-CELLS IN THE PERIPHERAL-BLOOD OF HIGH-DOSE CYCLOPHOSPHAMIDE-TREATED PATIENTS - ENHANCEMENT BY INTRAVENOUS RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].

SIENA, S ;

BREGNI, M ;

BRANDO, B ;

RAVAGNANI, F ;

BONADONNA, G ;

GIANNI, AM .

BLOOD, 1989, 74 (06) :1905-1914

[43] CD34+ SELECTED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) TO SUPPORT THE DELIVERY OF MULTIPLE CYCLES OF DOSE-INTENSIVE CYCLOPHOSPHAMIDE AND DOXORUBICIN (CD) WITH G-CSF PLUS ERYTHROPOIETIN (EPO) IN CHEMOTHERAPY-NAIVE BREAST-CANCER PATIENTS [J].

DEMETRI, GD ;

BERENSON, RJ ;

CAP, B ;

BLUMSACK, R ;

SHAPIRO, T ;

AUSTIN, E ;

SUGRUE, M ;

HAYES, DF .

BLOOD, 1994, 84 (10) :A207-A207

[44] PHASE-II STUDY OF AUTOLOGOUS FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO RESTORE HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY FOR LYMPHOID MALIGNANCIES (VOL 14, PG 105, 1994) [J].

SHERIDAN, WP ;

BEGLEY, CG ;

TO, LT ;

GRIGG, A ;

SZER, J ;

MAHER, D ;

GREEN, MD ;

ROWLINGS, PA ;

MCGRATH, KM ;

CEBON, J ;

DYSON, P ;

WATSON, D ;

BAYLY, J ;

DELUCA, E ;

TOMITA, D ;

HOFFMAN, E ;

MORSTYN, G ;

JUTTNER, CA ;

FOX, RM .

BONE MARROW TRANSPLANTATION, 1995, 15 (04) :654-654

[45] Randomized study of CD34+Peripheral Blood Stem Cells (PBSC) mobilization by lenograstim (Gly-G-CSF) given in a single dose compared to same split dose after high-dose cyclophosphamide: preliminary results [J].

Quittet, P ;

Legouffe, E ;

Lopez, E ;

Fegueux, N ;

Lu, Z ;

Klein, B ;

Rossi, J .

BONE MARROW TRANSPLANTATION, 2001, 27 :S166-S166

[46] THE INFLUENCE OF PRIOR CHEMOTHERAPY ON THE ABILITY OF PERIPHERAL-BLOOD DERIVED CD34+ CELLS MOBILIZED BY STEM-CELL FACTOR (SCF)PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)TO GENERATE PROGENITORS EX-VIVO [J].

SHAPIRO, F ;

MOSKOWITZ, C ;

REICH, L ;

MCNIECE, I ;

HEIMFELD, S ;

NIMER, S ;

GABRILOVE, J ;

MOORE, MAS .

BLOOD, 1994, 84 (10) :A586-A586

[47] Short- and long-term hematopoietic reconstitution after 1,019 courses of high-dose chemotherapy and peripheral blood progenitor cell support in a single institution adopting the 2x106 CD34+ cells/Kg threshold [J].

Bertolini, F ;

Corsini, C ;

Mancuso, P ;

Tealdo, F ;

Massaro, C ;

Rabascio, C ;

Paolucci, M ;

Burlini, A ;

Agazzi, A ;

Cinieri, S ;

Peccatori, F ;

Martinelli, G .

BONE MARROW TRANSPLANTATION, 2002, 29 :S204-S204

[48] COMPARATIVE EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY [J].

PETERS, WP ;

ROSNER, G ;

ROSS, M ;

VREDENBURGH, J ;

MEISENBERG, B ;

GILBERT, C ;

KURTZBERG, J .

BLOOD, 1993, 81 (07) :1709-1719

[49] Up-front use of plerixafor combined with chemotherapy and G-CSF in hard-to-mobilise lymphoma patients gives a satisfactory yield of CD34 cells within 1-2 days of apheresis and shows a sustained engraftment following high-dose therapy [J].

Josefsen, D. ;

Hetland, G. ;

Holte, H. ;

Kvalheim, G. .

BONE MARROW TRANSPLANTATION, 2012, 47 :S238-S239

[50] IL-11+G-CSF after high dose ifosfamide, carboplatin and etoposide mobilizes large numbers of CD34+ and CD34+/41+ progenitor cells into peripheral blood sufficient for rapid hematopoietic reconstitution post myeloablative therapy in heavily pretreated pediatric solid tumor patients. [J].

Goldman, SG ;

Kirov, I ;

Davenport, G ;

Cairo, MS .

EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) :711-711

← 1 2 3 4 5 →